| Investigator | Title | Sponsor | ID | Dates | Amount | 
        
            | Andrew J Stacy, PhD | Stacy T32 | University of Cincinnati (National Institutes of Health) National Institues of Health (NIH) | 1016232 | 8/1/2020-6/30/2021 | $48,312 | 
        
            | Biplab DasGupta, PhD | Biguanide Sensitivity of Glioma Stem Cells | Ntl Inst of Neuro Disorders & Stroke National Institues of Health (NIH) | R01NS099162 | 12/1/2020-11/30/2021 | $341,397 | 
        
            | Biplab DasGupta, PhD | Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and Challenges | Ntl Inst of Neuro Disorders & Stroke National Institues of Health (NIH) | R01NS114074 | 12/1/2020-11/30/2021 | $415,647 | 
        
            | Biplab DasGupta, PhD | Co-targeting S6 and TAM kinases in PTEN-deficient Glioblastoma | University of Cincinnati (National Cancer Institute) National Institues of Health (NIH) | 12653-002 | 12/1/2020-11/30/2021 | $21,630 | 
        
            | James Geller, MD | Geller Vice Chair Renal Tumor Committee | Children's Oncology Group (National Cancer Institute) National Institues of Health (NIH) | 9500080220-XX | 3/1/2020-2/28/2021 | $7,754 | 
        
            | James Geller, MD | Geller COG NCTN Study Chair | Children's Hospital of Philadelphia (National Cancer Institute) National Institues of Health (NIH) | Geller CHOP 20110742 | 3/1/2020-2/28/2021 | $7,754 | 
        
            | James Geller, MD | Geller AHEP 1531 COG Chair | Children's Hospital of Philadelphia (National Cancer Institute) National Institues of Health (NIH) | U10CA180886 | 3/1/2020-2/28/2021 | $15,508 | 
        
            | James Geller, MD | Geller AREN 1921 COG Study | Children's Oncology Group | AREN1921 | 6/1/2020-5/31/2025 | $82,212 | 
        
            | James Geller, MD | Geller AREN 1921 Study Chair | Children's Hospital of Philadelphia (National Cancer Institute) National Institues of Health (NIH) | U10CA180886 | 3/1/2020-2/28/2021 | $7,754 | 
        
            | John P Perentesis, MD | COG NCTN Workload Intensity General | Children's Hospital of Philadelphia (National Institutes of Health) National Institues of Health (NIH) | 2U10CA180886 | 3/1/2020-2/28/2021 | $132,150 | 
        
            | Kanimozhi Vairamani, PhD | Environmental Carcinogenesis and Mutagenesis | University of Cincinnati (Ntl Inst of Environmental Hlth Sciences) National Institues of Health (NIH) | T32ES007250 | 7/1/2020-8/31/2020 | $9,126 | 
        
            | Kaylin G Earnest, PhD | Earnest T32 2019 | University of Cincinnati (National Institutes of Health) National Institues of Health (NIH) | 1015348 | 9/1/2020-8/31/2021 | $60,830 | 
        
            | Lisa Marie Privette Vinnedge, PhD | Mechanisms coupling DEK to oncogenesis | National Cancer Institute National Institues of Health (NIH) | R01CA218072 | 2/1/2021-1/31/2022 | $363,712 | 
        
            | Lisa Marie Privette Vinnedge, PhD | Privette LIFE-UC 2019 | University of Cincinnati (Life Sciences Research Foundation) | LIFE FND 2019 | 11/1/2019-10/31/2020 | $4,500 | 
        
            | Lisa Marie Privette Vinnedge, PhD | Evaluating the role of ionizing radiation induced DNA damage in the developing mammary gland | University of Cincinnati Cancer Center | Privette, Lisa, UCCC | 7/1/2020-6/30/2021 | $50,000 | 
        
            | Lynn H Lee, MD | Targeting MBNL1-mediated alternative splicing in MLL-fusion leukemia | St. Baldrick's Foundation | AwardID: 638749 | 7/1/2020-6/30/2021 | $110,000 | 
        
            | Lynn H Lee, MD | Targeting MBNL1-mediated alternative splicing in MLL-fusion leukemia | National Cancer Institute National Institues of Health (NIH) | K08CA237753 | 3/25/2021-2/28/2022 | $196,112 | 
        
            | Maureen O'Brien, MD | Scientific Advosir Board service | Alex's Lemonade Stand Foundation | O'Brien, Maureen ALS | 12/1/2020-11/30/2021 | $10,000 | 
        
            | Maureen O'Brien, MD | O'Brien COG NCTN Study Chair 2019 | Children's Hospital of Philadelphia (National Cancer Institute) National Institues of Health (NIH) | U10CA180886 | 3/1/2020-2/28/2021 | $23,262 | 
        
            | Megan Johnstone, PhD | Johnstone T32 | University of Cincinnati (National Cancer Institute) National Institues of Health (NIH) | 1014415 | 9/1/2020-8/31/2021 | $55,596 | 
        
            | Megan Johnstone, PhD | Investigating the role of ovarian hormones on secondary breast cancer risk following radiation therapy during puberty | Cancer Free Kids | Johnstone, M., CFK | 7/1/2020-6/30/2021 | $50,000 | 
        
            | Michael J Absalon, MDPhD | A Phase I Study of Venetoclax and Vyxeos (CPX-351) for Children, Adolescents, and Young Adults with Relapsed Acute Leukemia | Michigan State University (Conquer Cancer Foundation) | RC111290 CHMC | 7/1/2020-6/30/2021 | $46,500 | 
        
            | Natasha Pillay-Smiley, DO | Pilay Smiley / Lurie / LGG14C03 | Lurie Children's Hospital of Chicago | LGG-14C03 | 8/17/2020-8/16/2025 | $2,001 | 
        
            | Natasha Pillay-Smiley, DO | The Pediatric Brain Tumor Consortium | St Jude's Children's Hospital (National Cancer Institute) National Institues of Health (NIH) | 110068210-7947557 | 5/22/2020-3/31/2021 | $88,444 | 
        
            | Natasha Pillay-Smiley, DO | The Pediatric Brain Tumor Consortium | St Jude's Children's Hospital (National Cancer Institute) National Institues of Health (NIH) | 110068210-7947557 | 5/22/2020-3/31/2021 | $26,175 | 
        
            | Peter Matthew Kennedy de Blank, MD | De Blank NIH-COG | Children's Hospital of Philadelphia (National Cancer Institute) National Institues of Health (NIH) | 20115662 - RSUB | 3/1/2019-2/28/2021 | $30,819 | 
        
            | Rajaram Nagarajan, MD | Research into Visual Endpoints and RB Health Outcomes after Treatment: The RIVERBOAT consortium. | Vanderbilt University Medical Center (National Cancer Institute) National Institues of Health (NIH) | VUMV67585 | 8/1/2020-7/31/2021 | $22,821 | 
        
            | Robin E Norris, MD, MPH | Norris COG Specimen Supplement | Children's Hospital of Philadelphia (National Institute for Health Research) | FP00033922_SUB04_01 | 3/1/2020-2/28/2021 | $5,900 | 
        
            | Susanne Wells, PhD | FA Pathway Activities in the Normal and Transformed Epidermis | National Cancer Institute National Institues of Health (NIH) | R01CA223790 | 8/1/2020-7/31/2021 | $363,713 | 
        
            | Susanne Wells, PhD | Strengthening epidermal defenses for the prevention of HPV infection and | National Cancer Institute National Institues of Health (NIH) | R01CA228113 | 12/1/2020-11/30/2021 | $367,049 | 
        
            | Susanne Wells, PhD | New activities of the human DEK oncogene | National Cancer Institute National Institues of Health (NIH) | R01CA239605 | 12/1/2020-11/30/2021 | $362,374 | 
        
            | Trent Hummel, MD | DIPG | The Cure Starts Now Foundation | Dewire, DIPG | 12/10/2019-12/9/2020 | $11 | 
        
            | Trent Hummel, MD | Targeting epienetic dysregulation in pediatric cancer | Dana Farber Cancer Institute (Stand Up to Cancer) | 6332101 | 1/1/2020-12/31/2021 | $33,797 | 
        
            | Total Annual Grant Award Dollars | $3,362,860 |